Pharmaceutical Contract Manufacturing & Contract Research Market Size & Forecast Report, 2014 - 2025

Global Pharmaceutical Contract Manufacturing & Contract Research Market is anticipated to reach USD 238.3 billion by 2025. Contract manufacturing offers supports to the complete outsourcing market, due to its widespread adoption and popularity by pharmaceutical establishments. The factors that propel the growth of the Pharmaceutical Contract Manufacturing & Contract Research industry include decrease in the cost of production of APIs, increasing focus on cost reduction, the rising price pressure.

On the other hand, there are factors that may hamper the growth of the market including stringent rules and regulations, and steady improvement. Pharmaceutical Contract Manufacturing & Contract Research Market is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Pharmaceutical Contract Manufacturing & Contract Research industry may be explored by type, application, and geography. The market may be explored by product type as Finished Dosage Formulations (FDF); which may further include (Parenteral/Injectables, Tablet, Oral Liquids, Capsule, Others), Active Pharmaceutical Ingredients (API), OTC Medicines and Nutritional Products, Advanced Drug Delivery Products, and Others. The “Active Pharmaceutical Ingredients (API)” segment led the Pharmaceutical Contract Manufacturing & Contract Research Market in 2016 and is anticipated to maintain its dominance by 2025 due to increasing demand for High Potency Active Pharmaceutical Ingredients (HPAPI).

The key applications that could be explored in the Pharmaceutical Contract Manufacturing & Contract Research industry include Biopharmaceutical, and Pharmaceutical. The market by end users could span Non-sterile, and Sterile. North America accounted for the major share of the Pharmaceutical Contract Manufacturing & Contract Research Market Size in 2016 and will continue to lead in the forecast period. However, Asia Pacific is anticipated to raise at a surplus rate. The factors that could be attributed to the growth include increase in number of corporations outsourcing the schemes in the emerging economies.

Some of the key players that fuel the growth of the Pharmaceutical Contract Manufacturing & Contract Research industry comprise Pharmaceutical Product Development LLC, Catalent, AbbVie, Patheon, Baxter Biopharma Solutions, Dalton Pharma Services, Grifols International, S.A., and Lonza AG., and Boehringer Ingelheim Biopharmaceuticals GmBh. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Market Segment:

Pharmaceutical Contract Manufacturing/Contract Research Market, Service Types Outlook (Revenue, USD Billion, 2014 - 2025)
    • Manufacturing Services (CMO)
        • API/Bulk Drugs
        • Advanced Drug Delivery Formulations Packaging
        • Packaging
        • Finished Dose Formulations
            • Solid Formulations
            • Liquid Formulations
            • Semi-solid Formulations
    • Research Services (CRO)
        • Oncology
        • Vaccines
        • Inflammation & Immunology
        • Cardiology
        • Neuroscience
        • Others

Pharmaceutical Contract Manufacturing/Contract Research Market Regional Outlook (Revenue, USD Billion, 2014 - 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • UK
    • Asia Pacific
        • India
        • China
    • Latin America
        • Brazil
        • Mexico
        • Colombia
        • Argentina
        • Chile
        • Venezuela
    • Middle East and Africa (MEA)
        • South Africa